Senti Biosciences Holdings, Inc.
SNTI
$0.30
-$0.02-5.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 6.25% | -27.27% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.25% | -27.27% | |||
| Cost of Revenue | 47.07% | -31.95% | |||
| Gross Profit | -47.20% | 31.96% | |||
| SG&A Expenses | -6.66% | 1,354.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.16% | 39.73% | |||
| Operating Income | -18.17% | -39.91% | |||
| Income Before Tax | -202.06% | 70.82% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -202.06% | 70.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -202.06% | 70.82% | |||
| EBIT | -18.17% | -39.91% | |||
| EBITDA | -19.53% | -47.63% | |||
| EPS Basic | -200.37% | 74.21% | |||
| Normalized Basic EPS | -14.19% | -4.28% | |||
| EPS Diluted | -200.37% | 74.21% | |||
| Normalized Diluted EPS | -14.19% | -4.28% | |||
| Average Basic Shares Outstanding | 0.56% | 13.12% | |||
| Average Diluted Shares Outstanding | 0.56% | 13.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||